O

Odyssey Therapeutics, Inc. Common Stock

ODTXNASDAQHEALTHCARE
$17.01-0.91 (-5.08%)
Market closedPrev close $17.92

Price action

Daily adjusted bars

2signals overlaid
Prior signal2

Snapshot

Key stats

AV May 29
Market cap
$851.5M
P/E ratio
--
Forward P/E
--
Beta
--
52W range
$15.35 - $20.30
Dividend yield
--
Volume
165.3K
Sector
HEALTHCARE

Analyst

Consensus price target

Pending

No consensus target yet for this ticker.

AV OVERVIEW ships an aggregate analyst target when 3+ desks cover.

AlphaYou verdict

Insider Cluster

LONGLive
13/ 100
WeakScore 13 / 100Issued May 13, 2026

3 insiders bought $55.0M of ODTX this 14d.

  • Smart money10.8/40
  • Fundamentals0.0/35
  • Technicals0.0/15
  • Macro1.8/10

Receipts

Recent signals for this ticker

  • ContextMay 13
    Insider Cluster

    3 insiders bought $55.0M of ODTX this 14d.

    Watch · Mixed Evidence·Checkpoints pending
  • LONGMay 12
    Multi-Insider Cluster

    C-suite + 3 other insiders bought $20.3M of ODTX this 14d.

    Public Recommendation·Checkpoints pending

Smart money

Insider, fund, and political flow

Live7 receipts
  • insider buy

    Insider TPG GP A, LLC bought $25.0M

    +25000002.0
  • insider buy

    Director Dimension Capital II, L.P. bought $20.0M

    +39999996.0
  • insider buy

    10% owner SR ONE CAPITAL MANAGEMENT, LLC bought $10.0M

    +14999985.0
  • insider buy

    Director LEIDEN JEFFREY M bought $100K

    +200000.0
  • insider buy

    Chief Financial Officer Haas Jason bought $20K

    +60000.0
  • insider buy

    Director Li Nan (LN) bought $20.0M

    +39999996.0

Top trader activity

Pending

Copy-trading signal layer from real US-equity operators. Wires in once the CopyTrading feed is mapped to US-stock tickers.

BTC Astro risk regime

Pending

Cross-asset risk timing overlay. Used as context only, never a primary stock source.

Reputation

Sources and actors behind this ticker

Source families

Actors and filers

  • D7

    1

    -4.76%

    0.0% hit

    D15

    1

    -3.15%

    0.0% hit

    D30

    pending

  • Haas Jason

    INSIDER

    D7

    1

    -4.76%

    0.0% hit

    D15

    1

    -3.15%

    0.0% hit

    D30

    pending

  • D7

    1

    -4.76%

    0.0% hit

    D15

    1

    -3.15%

    0.0% hit

    D30

    pending

  • D7

    1

    -4.76%

    0.0% hit

    D15

    1

    -3.15%

    0.0% hit

    D30

    pending

Checkpoint ledger

Public recommendation outcomes

Pending

No public recommendation checkpoints have landed for this ticker yet.

D7 appears first, then D15 and D30 as the call matures.

Each row is a public recommendation. Alpha columns compare the frozen issued price with SPY, QQQ, and sector ETF checkpoints when available.

Raw source coverage

Primary-source receipt chain

100.0%
Linked
4
Events
1
Signals
1
Recs
Source coverage4/4
SEC EDGAR Form 44/4 linked
Recent source events
  • SEC EDGAR Form 4

    INSIDER BUY · May 12· source

    raw linked
  • SEC EDGAR Form 4

    INSIDER BUY · May 12· source

    raw linked
  • SEC EDGAR Form 4

    INSIDER BUY · May 12· source

    raw linked
  • SEC EDGAR Form 4

    INSIDER BUY · May 12· source

    raw linked

Fundamentals

Valuation, quality, growth

Live

Valuation

  • P/E--
  • Forward P/E--
  • P/S286.12
  • P/B--

Quality

  • Profit margin0.0%
  • Operating margin-10740.0%
  • ROE-85.5%
  • ROA-41.7%

Growth

  • Revenue YoY--
  • Earnings YoY--
  • Beta--
  • Dividend yield--

Technicals

Trend, momentum, levels

Pending

Not enough bars to compute technicals yet.

The chart needs at least 30 sessions before SMAs are honest.

Macro

Sector + regime context

Live
  • macro regime shift

    VIX 18.0 (mild) as of 2026-05-12

    +18.0
  • macro regime shift

    10y-2y spread 46bps (flattish) as of 2026-05-12

    +0.5
  • macro regime shift

    Industrial Production 101.8 (flat) as of 2026-03-01

    +101.8
  • macro regime shift

    Initial claims 200,000 vs 26w mean (ratio 0.93, subdued)

    +0.9
  • macro regime shift

    CPI YoY 3.95% (hot vs Fed target)

    +4.0

Earnings

EPS beat / miss history

Pending

No stored earnings history for this ticker.

The AV EARNINGS sweep backfills 8+ quarters per coverage cycle.

Debate

Key issues

Live
  • Bullish view

    • Insider TPG GP A, LLC bought $25.0M
    • Director Dimension Capital II, L.P. bought $20.0M
    • 10% owner SR ONE CAPITAL MANAGEMENT, LLC bought $10.0M
    • Director LEIDEN JEFFREY M bought $100K

    Bearish view

    • Pending dilution: 1 S-3/S-8 shelf in trailing 90d

Arguments are pulled from contributing receipts (Form 4 / 13F / fundamentals / macro) for this ticker. Each side carries the count of receipts behind it, not an analyst headline count.

Track record

Recommendation receipts

vs SPY

S&P 500

2 recs · 2L · 0S

Median alpha

-2.94%

Mean alpha

-2.94%

Hit rate

0.0%

Mean return

-3.70%

vs QQQ

Nasdaq-100

2 recs · 2L · 0S

Median alpha

-2.93%

Mean alpha

-2.93%

Hit rate

0.0%

Mean return

-3.70%

D7 recommendation-counted alpha. Each receipt aggregates same-day same-direction signals into one row to avoid double-counting.